HIV prevention drugs known as PrEP are highly effective, but many at risk don't know about them

LIVE from the NMA Convention Raheem DeVaughn Says The Time Is Now: Let’s End HIV in Our Communities

Set against the backdrop of the NMA conference, Executive Officers from the National Medical Association, Grammy Award Winning Artist and Advocate Raheem DeVaughn, and Gilead Sciences experts, are holding today an important conversation on HIV prevention and health equity. Black women continue to be disproportionately impacted by HIV despite advances in prevention options. Today’s event is designed to uplift voices, explore barriers to access, a…

HIV prevention drugs known as PrEP are highly effective, but many at risk don't know about them

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the HIV epidemic in the U.S.

Sexual, Gender Minority Communities Misperceive Risk of HIV

A new study shows low rates of pre-exposure prophylaxis (PrEP) prescribing to sexual and gender minority individuals living in North Carolina, indicating barriers like stigma and a misperception of risk as reasons for not using PrEP.